News tagged with vaccine trial
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
HIV & AIDS
May 19, 2013 |
5 / 5 (1) |
0
Lyme disease vaccine shows promise in clinical trial
(Medical Xpress)—The results of a phase 1/2 clinical trial in Europe of an investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory, and at Baxter International ...
Medications
May 13, 2013 |
not rated yet |
0
|
Competing antibodies may have limited the protection achieved in HIV vaccine trial in Thailand
Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people.
HIV & AIDS
May 06, 2013 |
not rated yet |
0
|
HIV 'cure' looks 'promising,' Danish scientists contend
(HealthDay)—Danish scientists testing a novel HIV treatment in human trials contend that they're confident their strategy will result in a cure for the AIDS-causing virus, according to news reports.
HIV & AIDS
Apr 29, 2013 |
5 / 5 (1) |
0
Pharma giant Novartis working on H7N9 vaccine
Swiss pharmaceuticals giant Novartis is researching a vaccine for the H7N9 strain of bird flu, its chief executive said Thursday, amid fears that the disease could mutate into a form that spreads among people.
Medications
Apr 25, 2013 |
not rated yet |
0
Better regulation needed for kids' flu vaccine
Flu vaccines given to children should be more rigorously tested before before being allowed onto the market, researchers say, to prevent a repeat of the 2010 vaccine release, which caused a spate of high ...
Medications
Apr 15, 2013 |
5 / 5 (1) |
0
Engineered small pox may kill liver cancer
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec ...
Cancer
Apr 10, 2013 |
5 / 5 (2) |
0
Research deciphers HIV attack plan
(Medical Xpress)—A new study by Los Alamos National Laboratory and University of Pennsylvania scientists defines previously unknown properties of transmitted HIV-1, the virus that causes AIDS. The viruses ...
HIV & AIDS
Apr 01, 2013 |
5 / 5 (1) |
0
|
Violence, vaccine fears keep polio from disappearing
Sixty years after the first successful polio vaccine trial, the disease has been wiped out in much of the world, but violence, conspiracy theories and lack of cash keep it from disappearing.
Diseases, Conditions, Syndromes
Mar 25, 2013 |
5 / 5 (1) |
1
Infusion of stem cells and specially generated T-cells from same donor improves leukemia survival
In a significant advance for harnessing the immune system to treat leukemias, researchers at Fred Hutchinson Cancer Research Center for the first time have successfully infused large numbers of donor T-cells specific for ...
Cancer
Feb 27, 2013 |
5 / 5 (2) |
0
|
Most newly approved biologics studied in peds population
(HealthDay)—The majority of biologics approved since 1997 include pediatric information in their labeling and have been studied in pediatric trials, according to a review published online Jan. 14 in Pediatrics.
Pediatrics
Jan 15, 2013 |
not rated yet |
0
New insights into HIV vaccine will improve drug development
Four years ago, a potential HIV vaccine showed promise against the virus that causes AIDS, but it fell short of providing the broad protection necessary to stem the spread of disease.
HIV & AIDS
Jan 10, 2013 |
not rated yet |
0
|
Vaccination reduces the risk of unvaccinated badger cubs testing tuberculosis positive
New evidence from a four-year field study has shown that BCG vaccination reduces the risk of tuberculosis infection in unvaccinated badger cubs in vaccinated groups, as well as in badgers that received the vaccine.
Diseases, Conditions, Syndromes
Dec 12, 2012 |
not rated yet |
0
First European randomized trial confirms new pneumococcal vaccine highly effective in infants
A new conjugate vaccine is highly effective (93%) at preventing invasive pneumococcal disease (IPD; meningitis, sepsis, bacteremic pneumonia, and other blood-borne infections) in infants younger than 2 years who are the most ...
Diseases, Conditions, Syndromes
Nov 15, 2012 |
not rated yet |
0
Clinical trials for bacterial meningitis treatments are not keeping pace with the rise of resistance
New vaccines and drug treatments are urgently needed for bacterial meningitis, a devastating disease which kills or maims around a fifth of people who contract it, according to medical experts writing in a new Series on bacterial ...
Diseases, Conditions, Syndromes
Nov 08, 2012 |
not rated yet |
1
|
